Template:Ergotamine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 36: Line 36:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]]
|-
|-
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[ERGOMAR (ergotamine tartrate) tablet|{{fontcolor|#6C7B8B|ERGOMAR (ergotamine tartrate) tablet}}]]'''''
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate) aerosol, metered<sup>®</sup> FDA Package Insert
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered warnings and precautions|Warnings and Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered use in specific populations|Use in Specific Populations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered nonclinical toxicology|Nonclinical Toxicology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered labels and packages|Labels and Packages]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[XXXXX labels and packages|Labels and Packages]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Medihaler ergotamine (ergotamine tartrate)  aerosol, metered
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on XXXXX
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|-
|}
|}

Revision as of 22:57, 11 February 2014